
Full profile: /officials/H001085
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Currently in
Previously
This bill aims to strengthen the United States' ability to manufacture biological products like vaccines, medicines, and cell therapies by investing in research, facilities, and workforce training. It would help American companies compete globally in the growing biomanufacturing industry while reducing dependence on other countries for critical health products. The legislation affects pharmaceutical companies, research institutions, workers entering the biotech field, and ultimately patients who rely on these medicines.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.